Cboe Global Markets Interest Paid increased by 93.2% to $28.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.1%, from $26.70M to $28.60M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 21.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.30M | $3.50M | $17.50M | $8.80M | $36.20M | $7.40M | $0.00 | $21.40M | $17.00M | $12.00M | $6.30M | $17.40M | $45.00M | $19.60M | $18.10M | $26.70M | $19.90M | $30.30M | $14.80M | $28.60M |
| QoQ Change | — | -52.1% | +400.0% | -49.7% | +311.4% | -79.6% | -100.0% | — | -20.6% | -29.4% | -47.5% | +176.2% | +158.6% | -56.4% | -7.7% | +47.5% | -25.5% | +52.3% | -51.2% | +93.2% |
| YoY Change | — | — | — | — | +395.9% | +111.4% | -100.0% | +143.2% | -53.0% | +62.2% | — | -18.7% | +164.7% | +63.3% | +187.3% | +53.4% | -55.8% | +54.6% | -18.2% | +7.1% |